Perseus Proteomics Inc.
Securities Code: 4882 Growth TSE
August 12, 2022
To all stakeholders,
Notice on Booking of Non-operating Income and Extraordinary Loss
Perseus Proteomics Inc. (The Company) announces that the non-operating income and extraordinary loss were booked in the first quarter of the fiscal year ending March 31, 2023. The details are as follows:
1. Non-operating income
The Company has booked foreign exchange gains of 10,626 thousand yen and subsidy income of 285 thousand yen respectively, as non-operating income.
2. Extraordinary loss
The Company has booked impairment loss of 55,020 thousand yen for its noncurrent assets as extraordinary loss in accordance with the Accounting Standard for Impairment of Fixed Assets.
3. Impact on financial results
The above items have been fully reflected in the "Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2023" announced today.
END
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Perseus Proteomics Inc. published this content on 12 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2022 06:38:47 UTC.